Fang Cai is a seasoned medical professional with extensive experience in biomarker discovery and clinical implementation. Currently serving as Medical Director of US Medical Rheumatology & Nephrology at Genentech since September 2022, Fang previously held the position of Scientific Director in Precision Medicine Immunology at AbbVie from January 2021 to September 2022. At Genentech, from June 2010 to January 2021, Fang progressed from Senior Scientific Manager & Biomarker Team Leader to Scientific Manager & Biomarker Team Leader, focusing on clinical study management and data analysis to support scientific hypotheses. The career also includes roles as Associate Specialist at the University of California, San Francisco, and Research Assistant II at Stanford University, alongside foundational experience as Senior Laboratory Technician at the University of Toronto and Postdoctoral Fellow at the University of Alabama at Birmingham. Fang holds a Certificate in Clinical Research Conduct and Management from the University of California, Berkeley, and an MD, MS in Medicine from Tianjin Medical University.
This person is not in any teams
This person is not in any offices